Organization · Venture Capital
Bluezone Capital
Bluezone Capital is an early-stage life sciences fund based in San Francisco, California, focusing on regenerative medicine and scalable technologies for cell and gene therapies.
Overview
What Bluezone Capital does
What Bluezone Capital is
Bluezone Capital is an early-stage life sciences fund based in San Francisco, California, focusing on regenerative medicine and scalable technologies for cell and gene therapies.
How it participates in the startup ecosystem
The current public profile supports funder and event host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder · Event host
- Last reviewed
- May 6, 2026
Official channels
Find Bluezone Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Bluezone Capital as a funder
Investment thesis
Bluezone Capital invests in early-stage life sciences companies focused on regenerative medicine, emphasizing scalable, AI-powered platforms that transition from treatment to cures.
Focus narrative
Bluezone Capital primarily targets early-stage companies within the life sciences sector, particularly those developing solutions in regenerative medicine. The fund's investment strategy is centered around scalable technologies that can significantly enhance the efficacy and accessibility of curative therapies.
Value beyond capital
Bluezone Capital provides more than just capital; the team comprises operators, scientists, and engineers with deep expertise in life sciences. This allows them to offer strategic guidance and support to portfolio companies, helping them navigate the complexities of developing and scaling innovative therapies.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 3
Portfolio context
Cellular Vehicles: Innovating drug formulation and dose preparation for next-generation therapies using microfluidics and AI. Noara Therapeutics: Developing RNA therapeutics through its machine-intelligence-guided MITREN platform. Mana.bio: An AI-driven drug-delivery company focusing on lipid nanoparticle formulations for gene therapy and RNA/DNA therapeutics.
Capability profile
Bluezone Capital as an event host
Event focus
Bluezone Capital invests in early-stage life sciences companies, specifically targeting innovative solutions in regenerative medicine. Their investment strategy emphasizes scalable technologies and platforms that can significantly extend human health spans.
Format narrative
Bluezone Capital organizes various events and forums, including luncheons and discussions focused on innovation in life sciences and regenerative medicine.
Participant value
Attendees gain insights into the latest advancements in regenerative medicine and opportunities for collaboration with leading innovators in the life sciences sector.
Format and cadence
- Event types
- meetup and forum
- Modality
- in-person
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
- Next recorded event
- January 14, 2026
- Next event location
- San Francisco, CA
Audience and fit
- Stages
- Pre-seed · Seed
- Audience
- Founders · Investors
- Sectors
- Regenerative Medicine
- Regions
- North AmericaUnited States
Speakers and past editions
Past editions
Recent events include the GP | LP Luncheon on the growing gap between breakthrough science and early capital, and the Investor & Founder Forum discussing the future of curative therapies.
Common questions
What to know about Bluezone Capital
Upseed classifies Bluezone Capital under the Venture Capital organization type. Its current public profile includes funder and event host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 6, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.